| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |